Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ1175-1,76
KB993-6,32
PKN68,8368,85-0,35
Msft437,75437,810,58
Nokia4,374,50,25
IBM249,29249,421,55
Mercedes-Benz Group AG53,8253,841,18
PFE23,9423,95-1,07
05.05.2025 20:29:39
Indexy online
AD Index online
select
AD Index online
 

  • 05.05.2025 18:00:00
Arjo-B Rg (Stockholm)
Poslední obchod Změna (%) Změna (SEK) Objem obchodů (SEK)
31,14 -0,06 -0,02 32 441 356
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 05.05.2025
Popis společnosti
Obecné informace
Název společnostiArjo AB (publ)
TickerARJO B
Kmenové akcie:Ordinary Shares Class B
Kmenové akcie:Ordinary Shares
RICARJOb.ST
ISINSE0010468116
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky31.12.2024
Počet zaměstnanců k 31.12.2024 7 173
Akcie v oběhu k 31.12.2024 272 369 573
MěnaSEK
Kontaktní informace
UliceHans Michelsensgatan 10
MěstoMALMO
PSČ211 20
ZeměSweden
Kontatní osobaSara Ehinger
Funkce kontaktní osobyVice President Investor Relations & Corporate Communications
Kontatní telefon46 723 597 794

Business Summary: Arjo AB (publ) is a Sweden-based supplier of products, services and solutions for people with reduced mobility and age-related health challenges. The Company’s offering includes products and solutions within the product segments Patient handling, Hygiene, Disinfection, Therapeutic surfaces, Venous Thromboembolism (VTE) prevention and Diagnostics. Additionally, the Company is offering its customers complementing services. The products comprise ceiling lifts, standing and raising aids, slings, floor lifters, among others. Arjo AB (publ) operates in more than 60 countries, which the Company divides into three geographical areas: North America, Western Europe and Rest of the World.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, Arjo AB (publ) revenues increased 3% to SEK11.29B. Net income applicable to common stockholders increased 4% to SEK498M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Depreciation/Amortization in SGA Other decrease of 16% to SEK192M (expense), Research & Development Expenditure.
Odvětvová klasifikace
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical Appliance and Supplies Manufacturing
NAICS2007Surgical Appliance & Supplies Mfg
NAICS1997Surgical Appliance and Supplies Manufacturing
SICSurgical Appliances And Supplies



  • Poslední aktualizace: 05.05.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Interim President, Interim Chief Executive OfficerNiclas Sjosward5120.01.2025
Vice Chairman of the BoardCarl Bennet7401.01.2018
Interim Chief Financial OfficerChristofer Carlsson5220.01.202520.01.2025
Executive Vice President - Human Resources and SustainabilityMarion Gullstrand68
Executive Vice President - Group Legal & Business Compliance, Board SecretaryIngrid Carlsson4901.01.2020
Executive Vice President, Supply Chain and Product Development & OperationsJonas Cederhage54
Executive Vice President Quality & Regulatory ComplianceMaria Fagerberg4801.01.2024
Executive Vice President, Global MarketingTobias Kramer41
Executive Vice President, Communication & Public Relations.Maria Nilsson4301.01.2022